Health Law & Business News

Purdue’s Guilty Plea Over OxyContin Marketing Accepted by Judge

Nov. 24, 2020, 6:12 PM

Purdue Pharma LP entered its guilty plea to criminal charges over its marketing of OxyContin, the highly addictive painkiller blamed for helping spark the U.S. opioid epidemic.

  • U.S. District Judge Madeline Arleo in Newark, New Jersey, Tuesday agreed to accept the drugmaker’s plea to three federal conspiracy charges over marketing campaigns for the opioid-based painkiller and internal monitoring of how the drug was used
  • Steve Miller, Purdue’s chairman, acknowledged the company’s guilt in connection with conspiracies to defraud the U.S. and violate anti-kickback laws through its OxyContin marketing and monitoring efforts over a decade
  • Arleo noted the company’s negotiated...

To read the full article log in. To learn more about a subscription click here.